June 2002
Volume 43, Issue 6
Free
Erratum  |   June 2002
Erratum
Investigative Ophthalmology & Visual Science June 2002, Vol.43, 1701. doi:
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Erratum. Invest. Ophthalmol. Vis. Sci. 2002;43(6):1701.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Erratum in: “Effect of Administration of CTLA-Ig as Protein or cDNA on Corneal Allograft Survival” by Comer et al. (Invest Ophthalmol Vis Sci. 2002;43:1095–1103). 
In Fig. 6B , the hatched line (representing AdCTLA) was plotted for 10 graft recipients, and not 5 as the amended figure has been. 
The online version of this article was corrected on May 17, 2002. 
Figure 6.
 
Corneal allograft survival after adenovirus-mediated gene transfer of CTLA4-Ig. (A) Ex vivo transduction of donor cornea with 5 × 107 PFU/mL AdCTLA before transplantation resulted in longer survival than in Ad0-transduced grafts. (B) Greater prolongation of graft survival was found after intravenous injection of AdCTLA on day 1 after transplantation. MST in Ad0-treated recipients was identical with that in unmodified control animals (data not shown).
Figure 6.
 
Corneal allograft survival after adenovirus-mediated gene transfer of CTLA4-Ig. (A) Ex vivo transduction of donor cornea with 5 × 107 PFU/mL AdCTLA before transplantation resulted in longer survival than in Ad0-transduced grafts. (B) Greater prolongation of graft survival was found after intravenous injection of AdCTLA on day 1 after transplantation. MST in Ad0-treated recipients was identical with that in unmodified control animals (data not shown).
 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×